Lungpacer Medical Inc. is a medical device company located in Vancouver, British Columbia. The company is developing and commercializing a novel therapeutic solution that addresses the significant health and cost issues associated with mechanical ventilation of critically ill patients in hospital Intensive Care Units (ICU).
The therapeutic technology aims to preserve the integrity and strength of the diaphragm muscle in critically ill patients. The proprietary Lungpacer system is designed to activate the diaphragm using a temporary, minimally invasive, transvascular nerve stimulation approach to save lives, improve surviving patient outcomes and greatly reduce hospital care costs.
As of March 2020, the Lungpacer Diaphragm Pacing Therapy System is limited by Federal (United States) law to investigational use. The device is not approved for sale in the United States or Europe.
President & CEO